Nick Charalampakis

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Purpose After therapy of localized gastric adenocarcinoma (GAC) patients, the costs of surveillance, relapse patterns, and possibility of salvage are unknown. Materials and Methods We identified 246 patients, who after having a negative peritoneal staging, received therapy (any therapy which included surgery) and were surveyed (every 3-6 months in the(More)
OBJECTIVE Patients with metastatic gastroesophageal adenocarcinoma (MGEAC) have a poor but heterogeneous clinical course. Some patients have an unusually favorable outcome. We sought to identify clinical variables associated with more favorable outcomes. METHODS Of 246 patients with MGEAC, we identified 64 who received systemic therapy and eventually(More)
  • 1